Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
created: Sept. 11, 2025, 8:01 p.m. | updated: Sept. 12, 2025, 7:03 p.m.
The public offering price, before underwriting discounts and commissions, for each share of common stock was $7.00.
All of the securities in the underwritten public offering were sold by the Company.
The common stock described above was offered by the Company pursuant to a shelf registration statement on Form S-3 (File No.
333-289988), including a base prospectus, previously filed with and subsequently declared effective by the Securities and Exchange Commission (the “SEC”).
Private Securities Litigation Reform Act of 1995, including statements regarding the intended use of proceeds from the offering.
1 month, 3 weeks ago: News Ticker - markets.businessinsider.com